A report released today by Zacks Investment Research about Evolent Health Inc (NYSE:EVH) bumps the target price to $28.00
- Updated: October 16, 2016
Just yesterday Evolent Health Inc (NYSE:EVH) traded -5.14% lower at $25.11. Evolent Health Inc’s 50-day average is $23.92 and its two hundred day average is $18.84. With the last stock price close up 27.46% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. 803,082 shares of Evolent Health Inc traded, up from an avg. volume of 374,302
In a statement issued on 10/11/2016 Zacks Investment Research upped the price target of Evolent Health Inc (NYSE:EVH) to $28.00 stating a possible upside of 0.12%.
Recent Performance Chart
Evolent Health Inc has with a one year low of $8.14 and a one year high of $26.84 and has a total market value of $0.
A total of 7 equity analysts have released a ratings update on EVH. Three equity analysts rating the company a strong buy, four brokers rating the stock a buy, 1 broker rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell with a average stock price target of $18.71.
General Information About Evolent Health Inc (NYSE:EVH)
Evolent Health, Inc. supports integrated health systems in their migration towards value-based care and population health management. The Company's services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services. Together these services enable health systems to manage patients' health. It provides an end-to-end, built-for-purpose, technology-enabled services platform for providers in value-based payment models. Its platform supports a diverse set of provider value-based care strategies. It provides the technology and services necessary for the models pursued by providers. The Company offers Identifi, a technology platform that aggregates and analyzes data, manages care workflows and engages patients. Its Value-Based Operations are empowered and supported by Identifi.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.